$97.6M in CY2024 Part D spend5.2M claims · 1.3M beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Ropinirole used for?
a non-ergoline dopamine agonist indicated for the treatment of Parkinson’s disease (PD) and moderate-to-severe primary Restless Legs Syndrome (RLS). (1.1, 1.2). 1.1 Parkinson's Disease Ropinirole t....
Is there a generic for Ropinirole?
Yes. 91 ANDAs filed at FDA, 13 generic manufacturers currently shipping.
How much does my plan pay for Ropinirole?
Across 329 Part D plans, Ropinirole averages $0.046/unit (NADAC). Lowest available: $0.043/unit. Highest in distribution: $0.052/unit.
Is Ropinirole on the FDA shortage list?
No. Ropinirole is not currently on the FDA Drug Shortage Database.
6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.